PURPOSE: In mass spectrometry (MS)-based studies to discover urinary protein biomarkers, an important question is how to analyze the data to find the most promising potential biomarkers to be advanced to large-scale validation studies. Here, we describe a "systems biology-based" approach to address this question. EXPERIMENTAL DESIGN: We analyzed large-scale liquid chromatography-tandem mass spectrometry (LC-MS/MS) data of urinary exosomes from renal allograft recipients with biopsy-proven evidence of immunological rejection or tubular injury (TI). We asked whether bioinformatic analysis of urinary exosomal proteins can identify biological-process based protein groups that correlate with biopsy findings and whether the protein groups fit with general knowledge of the pathophysiological mechanisms involved. RESULTS: LC-MS/MS analysis of urinary exosomal proteomes identified more than 1000 proteins in each pathologic group. These protein lists were analyzed computationally to identify the Biological Process and Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway terms that are significantly associated with each pathological group. Among the most informative terms for each group were: "sodium ion transport" for TI; "immune response" for all rejection; "epithelial cell differentiation" for cell-mediated rejection; and "acute inflammatory response" for antibody-mediated rejection. Based on these terms, candidate biomarkers were identified using a novel strategy to allow a dichotomous classification between different pathologic categories. CONCLUSIONS AND CLINICAL RELEVANCE: The terms and candidate biomarkers identified make rational connections to pathophysiological mechanisms, suggesting that the described bioinformatic approach will be useful in advancing large-scale biomarker identification studies toward a validation phase.
PURPOSE: In mass spectrometry (MS)-based studies to discover urinary protein biomarkers, an important question is how to analyze the data to find the most promising potential biomarkers to be advanced to large-scale validation studies. Here, we describe a "systems biology-based" approach to address this question. EXPERIMENTAL DESIGN: We analyzed large-scale liquid chromatography-tandem mass spectrometry (LC-MS/MS) data of urinary exosomes from renal allograft recipients with biopsy-proven evidence of immunological rejection or tubular injury (TI). We asked whether bioinformatic analysis of urinary exosomal proteins can identify biological-process based protein groups that correlate with biopsy findings and whether the protein groups fit with general knowledge of the pathophysiological mechanisms involved. RESULTS: LC-MS/MS analysis of urinary exosomal proteomes identified more than 1000 proteins in each pathologic group. These protein lists were analyzed computationally to identify the Biological Process and Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway terms that are significantly associated with each pathological group. Among the most informative terms for each group were: "sodium ion transport" for TI; "immune response" for all rejection; "epithelial cell differentiation" for cell-mediated rejection; and "acute inflammatory response" for antibody-mediated rejection. Based on these terms, candidate biomarkers were identified using a novel strategy to allow a dichotomous classification between different pathologic categories. CONCLUSIONS AND CLINICAL RELEVANCE: The terms and candidate biomarkers identified make rational connections to pathophysiological mechanisms, suggesting that the described bioinformatic approach will be useful in advancing large-scale biomarker identification studies toward a validation phase.
Authors: William Clarke; Benjamin C Silverman; Zhen Zhang; Daniel W Chan; Andrew S Klein; Ernesto P Molmenti Journal: Ann Surg Date: 2003-05 Impact factor: 12.969
Authors: Jennifer C Huling; Trairak Pisitkun; Jae H Song; Ming-Jiun Yu; Jason D Hoffert; Mark A Knepper Journal: Am J Physiol Renal Physiol Date: 2011-11-23
Authors: Sookkasem Khositseth; Trairak Pisitkun; Dane H Slentz; Guanghui Wang; Jason D Hoffert; Mark A Knepper; Ming-Jiun Yu Journal: Mol Cell Proteomics Date: 2010-10-12 Impact factor: 5.911
Authors: Lorraine C Racusen; Robert B Colvin; Kim Solez; Michael J Mihatsch; Philip F Halloran; Patricia M Campbell; Michael J Cecka; Jean-Pierre Cosyns; Anthony J Demetris; Michael C Fishbein; Agnes Fogo; Peter Furness; Ian W Gibson; Denis Glotz; Pekka Hayry; Lawrence Hunsickern; Michael Kashgarian; Ronald Kerman; Alex J Magil; Robert Montgomery; Kunio Morozumi; Volker Nickeleit; Parmjeet Randhawa; Heinz Regele; Daniel Seron; Surya Seshan; Stale Sund; Kiril Trpkov Journal: Am J Transplant Date: 2003-06 Impact factor: 8.086
Authors: Christina M Van Itallie; Amber Jean Tietgens; Angel Aponte; Karin Fredriksson; Alan S Fanning; Marjan Gucek; James M Anderson Journal: J Cell Sci Date: 2013-12-11 Impact factor: 5.285
Authors: Mahdi Salih; Jeroen A Demmers; Karel Bezstarosti; Wouter N Leonhard; Monique Losekoot; Cees van Kooten; Ron T Gansevoort; Dorien J M Peters; Robert Zietse; Ewout J Hoorn Journal: J Am Soc Nephrol Date: 2016-03-03 Impact factor: 10.121
Authors: Hua Zhou; Hiroshi Kajiyama; Takayuki Tsuji; Xuzhen Hu; Asada Leelahavanichkul; Suzanne Vento; Rachel Frank; Jeffrey B Kopp; Howard Trachtman; Robert A Star; Peter S T Yuen Journal: Am J Physiol Renal Physiol Date: 2013-06-12
Authors: Kaiyuan Wu; Lingdi Wang; Yong Chen; Mehdi Pirooznia; Komudi Singh; Sarah Wälde; Ralph H Kehlenbach; Iain Scott; Marjan Gucek; Michael N Sack Journal: J Cell Sci Date: 2018-11-20 Impact factor: 5.285